Please login to the form below

Not currently logged in
Email:
Password:

Forendo Pharma

This page shows the latest Forendo Pharma news and features for those working in and with pharma, biotech and healthcare.

Organon buys Forendo in $1bn deal

Organon buys Forendo in $1bn deal

Forendo purchase bolsters Organon’s pipeline with candidates in endometriosis and polycystic ovarian syndrome. ... Our acquisition of Forendo further demonstrates our commitment to building a pipeline of impactful treatment options for women with unmet

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Envisioning a healthier every day, for every woman Envisioning a healthier every day, for every woman

    To strive for new innovations, in the past year alone, Organon has acquired Alydia Health, a medical device manufacturer focused on women’s health, and Forendo Pharma, a clinical stage drug ... Digital inspiration for pharma on mobile, social media,

  • Deal Watch table for October 2014 Deal Watch table for October 2014

    For an indepth analysis of these deals, read'Pharma deals during October 2014'. ... 335. Forendo Pharma/Apricus Biosciences. Licence [A]. Fispemifene a selective oestrogen modulator in P2 for secondary hypogonadism.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • David Colpman joins Forendo Pharma’s board David Colpman joins Forendo Pharma’s board

    He becomes a non-executive director. Forendo Pharma, a drug development company, has appointed David Colpman to its board of directors. ... Risto Lammintausta, chief executive officer of Forendo Pharma, said: “We are delighted to welcome David with his

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Genesis Research Group

Genesis Research Group provides life science companies with a better way to develop impactful evidence and optimize market access by...

Latest intelligence

New Playbook Alert: Virtual Patient Engagement
...
Millennials: the wellness generation
Looking at the results from a global healthcare research study focusing on the patients of the future...
The problem with clinical trials (and how virtual insight-gathering can help)
While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....